ClinicalTrials.gov
public full text
Public Domain
Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury
This trial is conducted in Asia, Europe, Middle East, and North America. The primary objective of the trial is to evaluate the safety of Recombinant Activated Factor VII in patients with brain contusions. The secondary objective of the trial is to evaluate the preliminary efficacy of Recombinant Activated Factor VII in preventing early haemorrhagic progression in contusive brain injury.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects#1058430
- Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment#981622
- The potential of human serum S100 Calcium-binding Protein B, Glial Fibrillary Acidic Protein, Neuron-Specific Enolase, and Serum Amyloid A as biomarkers for Traumatic Brain injury in moderate and severe cohort.#977199
- rhuFVIIa in Post-partum Hemorrhage#981699
- Serum Neuroglobin and Nogo-A Concentrations in Acute Traumatic Brain Injury#829194
Record · ID 1321441
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive